274 related articles for article (PubMed ID: 26404953)
21. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
22. Colorectal adenoma characteristics as predictors of recurrence.
Bonithon-Kopp C; Piard F; Fenger C; Cabeza E; O'Morain C; Kronborg O; Faivre J;
Dis Colon Rectum; 2004 Mar; 47(3):323-33. PubMed ID: 14991494
[TBL] [Abstract][Full Text] [Related]
23. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
[TBL] [Abstract][Full Text] [Related]
24. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
Chu DZ; Chansky K; Alberts DS; Meyskens FL; Fenoglio-Preiser CM; Rivkin SE; Mills GM; Giguere JK; Goodman GE; Abbruzzese JL; Lippman SM
Ann Surg Oncol; 2003 Oct; 10(8):870-5. PubMed ID: 14527904
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.
Barry EL; Peacock JL; Rees JR; Bostick RM; Robertson DJ; Bresalier RS; Baron JA
JAMA Oncol; 2017 May; 3(5):628-635. PubMed ID: 27978548
[TBL] [Abstract][Full Text] [Related]
26. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
Grau MV; Baron JA; Sandler RS; Wallace K; Haile RW; Church TR; Beck GJ; Summers RW; Barry EL; Cole BF; Snover DC; Rothstein R; Mandel JS
J Natl Cancer Inst; 2007 Jan; 99(2):129-36. PubMed ID: 17227996
[TBL] [Abstract][Full Text] [Related]
27. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Chen YX; Gao QY; Zou TH; Wang BM; Liu SD; Sheng JQ; Ren JL; Zou XP; Liu ZJ; Song YY; Xiao B; Sun XM; Dou XT; Cao HL; Yang XN; Li N; Kang Q; Zhu W; Xu HZ; Chen HM; Cao XC; Fang JY
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):267-275. PubMed ID: 31926918
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
[TBL] [Abstract][Full Text] [Related]
29. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
30. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
Chung SJ; Kim YS; Yang SY; Song JH; Kim D; Park MJ; Kim SG; Song IS; Kim JS
Gut; 2011 Nov; 60(11):1537-43. PubMed ID: 21427200
[TBL] [Abstract][Full Text] [Related]
31. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.
Benamouzig R; Deyra J; Martin A; Girard B; Jullian E; Piednoir B; Couturier D; Coste T; Little J; Chaussade S
Gastroenterology; 2003 Aug; 125(2):328-36. PubMed ID: 12891533
[TBL] [Abstract][Full Text] [Related]
32. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials.
Gao F; Liao C; Liu L; Tan A; Cao Y; Mo Z
Colorectal Dis; 2009 Nov; 11(9):893-901. PubMed ID: 19055515
[TBL] [Abstract][Full Text] [Related]
33. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
[TBL] [Abstract][Full Text] [Related]
34. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
[TBL] [Abstract][Full Text] [Related]
36. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial.
Ishikawa H; Mutoh M; Suzuki S; Tokudome S; Saida Y; Abe T; Okamura S; Tajika M; Joh T; Tanaka S; Kudo SE; Matsuda T; Iimuro M; Yukawa T; Takayama T; Sato Y; Lee K; Kitamura S; Mizuno M; Sano Y; Gondo N; Sugimoto K; Kusunoki M; Goto C; Matsuura N; Sakai T; Wakabayashi K
Gut; 2014 Nov; 63(11):1755-9. PubMed ID: 24488498
[TBL] [Abstract][Full Text] [Related]
37. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants.
Hofstad B; Almendingen K; Vatn M; Andersen SN; Owen RW; Larsen S; Osnes M
Digestion; 1998; 59(2):148-56. PubMed ID: 9586828
[TBL] [Abstract][Full Text] [Related]
38. Calcium supplements and colorectal adenomas. Polyp Prevention Study Group.
Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Frankl H; Pearson L; Bond JH; Greenberg ER
Ann N Y Acad Sci; 1999; 889():138-45. PubMed ID: 10668490
[TBL] [Abstract][Full Text] [Related]
39. The association between location, age and advanced colorectal adenoma characteristics: a propensity-matched analysis.
Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
Scand J Gastroenterol; 2017 Jan; 52(1):1-4. PubMed ID: 27686516
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
